Darzalex Daratumumab 500 mg Injection
Darzalex Daratumumab 500 mg Injection is a targeted immunotherapy used for the treatment of Multiple Myeloma, a type of blood cancer that affects plasma cells in the bone marrow.
It contains daratumumab, a monoclonal antibody that binds specifically to the CD38 protein on cancer cells. This helps the immune system recognize and destroy malignant plasma cells, slowing disease progression and improving patient outcomes. The 500 mg formulation is commonly used in combination therapy for multiple myeloma management.
📞 Contact Details to Place Order
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com
Composition & Content
- Active Ingredient: Daratumumab – 500 mg
- Drug Class: CD38-directed monoclonal antibody
- Formulation: Sterile injectable solution (IV or subcutaneous depending on protocol)
- Excipients: Stabilizers, buffers, and sterile water for injection
How to Use
- Administered only by trained healthcare professionals
- Given via intravenous infusion or subcutaneous injection depending on treatment protocol
- Pre-medication (antihistamines, corticosteroids, antipyretics) is recommended
- Patients should be monitored during and after administration for reactions
Dosage
Dosage is individualized by an oncologist:
- Initial phase: Weekly administration
- Intermediate phase: Every 2 weeks
- Maintenance phase: Monthly dosing
- Often combined with other anti-myeloma drugs for better efficacy
Uses & Treatments
Darzalex 500 mg Injection is used for:
- Newly diagnosed multiple myeloma
- Relapsed or refractory multiple myeloma
- Combination therapy with chemotherapy or immunotherapy agents
- Long-term maintenance therapy under oncology supervision
Advantages
- Targets CD38-positive cancer cells precisely
- Improves survival outcomes in multiple myeloma
- Can be combined with standard treatment regimens
- Reduces tumor progression effectively
- Well-established immunotherapy in hematology oncology
Storage Conditions
- Store in a refrigerator at 2°C to 8°C
- Do not freeze
- Keep in original packaging to protect from light
- Do not shake
- Keep out of reach of children
Alternative Indian Brands / Options
Currently, Daratumumab is mainly available under the innovator brand Darzalex globally. In India, alternative options may include:
- Daratumumab biosimilars (availability depends on regulatory approvals)
- Other multiple myeloma treatment options:
- Bortezomib
- Lenalidomide
- Carfilzomib
All treatments must be prescribed and supervised by a qualified oncologist.
Buy Darzalex Daratumumab 500 mg Injection in USA – GlobMedIndia
Looking to buy Darzalex Daratumumab 500 mg Injection in the United States of America? GlobMedIndia – The Medicine Exporter provides fast, safe, and secure international access to anti-cancer medicines across major US cities with reliable global supply support.
We serve key locations including:
- California
- Washington
- Chicago
- Los Angeles
- Houston
- Phoenix
- Austin
- Columbus
- Philadelphia
- San Antonio
- San Diego
- Dallas
- Jacksonville
🌟 Why Choose GlobMedIndia?
- Trusted global oncology medicine exporter
- Secure cold-chain pharmaceutical handling
- Fast international delivery support
- Quality-assured sourcing of medicines
- Dedicated support for prescription-based orders
